Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
Ottaiano A, Mollo E, Di Lorenzo G, Pisano C, Di Maio M, Barletta E, Pensabene M, Segati R, Bullian P, Nasti G, Bryce J, Scala S, Castello G, Ascierto PA. Ottaiano A, et al. Among authors: pisano c. Cancer Immunol Immunother. 2005 Jan;54(1):44-50. doi: 10.1007/s00262-004-0567-z. Cancer Immunol Immunother. 2005. PMID: 15693138 Free PMC article. Review.
CD40 activation as potential tool in malignant neoplasms.
Ottaiano A, Pisano C, De Chiara A, Ascierto PA, Botti G, Barletta E, Apice G, Gridelli C, Iaffaioli VR. Ottaiano A, et al. Among authors: pisano c. Tumori. 2002 Sep-Oct;88(5):361-6. doi: 10.1177/030089160208800502. Tumori. 2002. PMID: 12487551 Review.
Prognostic value of CD40 in adult soft tissue sarcomas.
Ottaiano A, De Chiara A, Perrone F, Botti G, Fazioli F, De Rosa V, Mozzillo N, Ravo V, Morrica B, Gallo C, Pisano C, Napolitano M, Ascierto PA, Iaffaioli RV, Apice G. Ottaiano A, et al. Among authors: pisano c. Clin Cancer Res. 2004 Apr 15;10(8):2824-31. doi: 10.1158/1078-0432.ccr-0139-03. Clin Cancer Res. 2004. PMID: 15102691
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
Pignata S, De Placido S, Biamonte R, Scambia G, Di Vagno G, Colucci G, Febbraro A, Marinaccio M, Lombardi AV, Manzione L, Cartenì G, Nardi M, Danese S, Valerio MR, de Matteis A, Massidda B, Gasparini G, Di Maio M, Pisano C, Perrone F. Pignata S, et al. Among authors: pisano c. BMC Cancer. 2006 Jan 7;6:5. doi: 10.1186/1471-2407-6-5. BMC Cancer. 2006. PMID: 16398939 Free PMC article. Clinical Trial.
419 results